Document Classification

Section Type: METHODS

Text: Patients with previously untreated stage III or IV (excluding T1-2N1 and M1) squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx were randomly assigned to receive definitive radiotherapy (70 Gy in 7 weeks) concurrently with either CIS (100 mg/m (2)) on day 1 of weeks 1, 4, and 7 or CIS (75 mg/m (2)) plus TPZ (290 mg/m (2) / d) on day 1 of weeks 1, 4, and 7 and TPZ alone (160 mg/m (2) / d) on days 1, 3, and 5 of weeks 2 and 3 (TPZ/CIS).